Product Watch

Premium

Mo Bio Laboratories this week launched the RTS DNase kit for removing contaminating genomic DNA from RNA preparations while protecting the RNA samples from damage during the DNase treatment process.

The kit includes the first room-temperature-stable DNase I enzyme, which eliminates concerns over freeze-thaw cycles that may decrease enzymatic activity. The kit also contains a highly specific resin that is used to bind and remove the RTS DNase enzyme and divalent cations from the reaction for optimal qPCR results, Mo Bio said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.

A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.

Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.

Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."